BE2014C001I2 - - Google Patents
Download PDFInfo
- Publication number
- BE2014C001I2 BE2014C001I2 BE2014C001C BE2014C001C BE2014C001I2 BE 2014C001 I2 BE2014C001 I2 BE 2014C001I2 BE 2014C001 C BE2014C001 C BE 2014C001C BE 2014C001 C BE2014C001 C BE 2014C001C BE 2014C001 I2 BE2014C001 I2 BE 2014C001I2
- Authority
- BE
- Belgium
- Prior art keywords
- composition
- aliphatic
- mixture
- ester
- buffer system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/480,738 US6323241B1 (en) | 2000-01-10 | 2000-01-10 | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
PCT/US2001/000852 WO2001051053A1 (fr) | 2000-01-10 | 2001-01-10 | Compositions de prostaglandine et procede de traitement de dyserection male |
Publications (1)
Publication Number | Publication Date |
---|---|
BE2014C001I2 true BE2014C001I2 (fr) | 2020-01-30 |
Family
ID=23909154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2014C001C BE2014C001I2 (fr) | 2000-01-10 | 2014-01-06 |
Country Status (20)
Country | Link |
---|---|
US (1) | US6323241B1 (fr) |
EP (1) | EP1255552B1 (fr) |
JP (2) | JP2003519657A (fr) |
KR (1) | KR100614361B1 (fr) |
CN (1) | CN1394140A (fr) |
AT (1) | ATE290383T1 (fr) |
AU (1) | AU760576C (fr) |
BE (1) | BE2014C001I2 (fr) |
BR (1) | BR0107478A (fr) |
CA (1) | CA2395217C (fr) |
DE (1) | DE60109274T2 (fr) |
ES (1) | ES2236245T3 (fr) |
HK (1) | HK1047700B (fr) |
HU (1) | HUP0204159A3 (fr) |
IL (2) | IL150306A0 (fr) |
MX (1) | MXPA02006758A (fr) |
PT (1) | PT1255552E (fr) |
TR (1) | TR200201769T2 (fr) |
WO (1) | WO2001051053A1 (fr) |
ZA (1) | ZA200205433B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR1002847B (el) | 1997-05-06 | 1998-01-27 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
US6414028B1 (en) * | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
US20050004226A1 (en) * | 1998-12-10 | 2005-01-06 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
EA008720B1 (ru) * | 1998-12-10 | 2007-06-29 | Нексмед (Холдингс), Инк. | Применение композиции на основе простагландина для лечения расстройства сексуального возбуждения у женщин |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US7105571B2 (en) * | 2000-01-10 | 2006-09-12 | Nexmed Holdings, Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US20040110843A1 (en) * | 2000-01-10 | 2004-06-10 | Nexmed (Holdings), Inc. | Methods of treatment of male erectile dysfunction |
US6693135B2 (en) * | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20090257956A1 (en) * | 2002-01-25 | 2009-10-15 | Ramsey Sallis | Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation |
US20090035221A1 (en) * | 2002-01-25 | 2009-02-05 | Ramsey Sallis | Methods and Compositions for Treatment of Erectile Dysfunction |
AU2003209350A1 (en) | 2002-01-25 | 2003-09-02 | Modular Properties Ltd | Methods and compositions for treating male erectile dysfunction |
HUP0402673A2 (hu) * | 2002-02-15 | 2005-04-28 | Nexmed (Holdings), Inc. | Erekciózavar kezelésére szolgáló prosztaglandin készítmény |
CN1674912A (zh) * | 2002-09-06 | 2005-09-28 | 奈克斯麦德控股有限公司 | 治疗男性勃起障碍的方法 |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
WO2004084861A2 (fr) * | 2003-03-21 | 2004-10-07 | Nexmed (Holdings), Inc. | Promotion de l'angiogenese par des compositions de prostaglandine et techniques a cet effet |
CA2517828C (fr) | 2003-03-21 | 2016-10-04 | Nexmed Holdings, Inc. | Compositions et procedes pour le traitement de l'ejaculation precoce |
EP1605948A1 (fr) * | 2003-03-21 | 2005-12-21 | Nexmed Holdings, Inc. | Compositions de prostaglandine pour le traitement de dyserection |
US20050009918A1 (en) * | 2003-04-02 | 2005-01-13 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods for the treatment of vasospasm |
US20050159985A1 (en) * | 2003-11-21 | 2005-07-21 | Bertram Carl T. | System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
US7655659B2 (en) * | 2004-08-19 | 2010-02-02 | Applied Genetics Incorporated Dermatics | Biomimetic of Evodia rutaecarpa fruit extract for amelioration of inflammation |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
US9005183B2 (en) * | 2007-05-16 | 2015-04-14 | Health Knight, Llc | System and method for treating erectile dysfunction |
WO2012075107A2 (fr) * | 2010-12-02 | 2012-06-07 | Nexmed Holdings, Inc. | Énantiomère actif du 2-(n,n-diméthylamino)-propionate dodécylique |
MX342511B (es) | 2011-04-07 | 2016-10-03 | Nexmed Holdings Inc | Metodos y composiciones para tratar la enfermedad de raynaud. |
US10226418B2 (en) | 2014-05-12 | 2019-03-12 | Susie Q, Ltd. | Arginine-containing topical composition |
US9657020B2 (en) | 2015-01-20 | 2017-05-23 | Xoc Pharmaceuticals, Inc. | Ergoline compounds and uses thereof |
CN107405346A (zh) | 2015-01-20 | 2017-11-28 | Xoc制药股份有限公司 | 异麦角灵化合物及其用途 |
EP3266458A1 (fr) | 2016-07-05 | 2018-01-10 | Fagron B.V. | Procédé et composition et kit pour traiter un dysfonctionnement érectile |
JP2020522504A (ja) | 2017-06-01 | 2020-07-30 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | 多環式化合物およびそれらの用途 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2818855A (en) | 1954-02-11 | 1958-01-07 | Anthony P Miller | Surgical device |
BE790840A (fr) | 1971-11-01 | 1973-04-30 | Upjohn Co | Solutions de medicaments instables et leur preparation |
US4127118B1 (en) | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
US4254145A (en) | 1978-08-16 | 1981-03-03 | American Cyanamid Company | Topical application of prostaglandin hypotensive agents |
US4311707A (en) | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
US4801587A (en) | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
US5256652A (en) | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
US4980378A (en) | 1988-06-01 | 1990-12-25 | Odontex, Inc. | Biodegradable absorption enhancers |
SE463851B (sv) | 1988-09-02 | 1991-02-04 | Amsu Ltd | Komposition foer behandling av erektil dysfunktion via uretra |
AU655420B2 (en) | 1990-04-25 | 1994-12-22 | Vivus, Inc. | Treatment of erectile dysfunction |
US5242391A (en) | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5380760A (en) | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
KR19980703052A (ko) | 1995-03-14 | 1998-09-05 | 윌리엄 엘. 스미스 | 발기 기능장애의 예방 방법 및 키트 |
KR20010021625A (ko) * | 1997-07-09 | 2001-03-15 | 추후보정 | 개선된 남성발기 기능장애 치료방법 및 그 조성물 |
JP2003525845A (ja) * | 1997-10-28 | 2003-09-02 | ヴィヴァス・インコーポレイテッド | 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの局所投与 |
US6046244A (en) | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
US5942545A (en) | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6102849A (en) | 1999-04-03 | 2000-08-15 | Hakac; John R. | Non-surgical penile prosthesis |
-
2000
- 2000-01-10 US US09/480,738 patent/US6323241B1/en not_active Expired - Lifetime
-
2001
- 2001-01-10 JP JP2001551477A patent/JP2003519657A/ja active Pending
- 2001-01-10 IL IL15030601A patent/IL150306A0/xx active IP Right Grant
- 2001-01-10 HU HU0204159A patent/HUP0204159A3/hu active IP Right Revival
- 2001-01-10 KR KR1020027008845A patent/KR100614361B1/ko active IP Right Grant
- 2001-01-10 DE DE60109274T patent/DE60109274T2/de not_active Expired - Lifetime
- 2001-01-10 CN CN01803447A patent/CN1394140A/zh active Pending
- 2001-01-10 ES ES01942300T patent/ES2236245T3/es not_active Expired - Lifetime
- 2001-01-10 CA CA002395217A patent/CA2395217C/fr not_active Expired - Lifetime
- 2001-01-10 BR BR0107478-4A patent/BR0107478A/pt not_active Application Discontinuation
- 2001-01-10 TR TR2002/01769T patent/TR200201769T2/xx unknown
- 2001-01-10 WO PCT/US2001/000852 patent/WO2001051053A1/fr active IP Right Grant
- 2001-01-10 MX MXPA02006758A patent/MXPA02006758A/es active IP Right Grant
- 2001-01-10 EP EP01942300A patent/EP1255552B1/fr not_active Expired - Lifetime
- 2001-01-10 AU AU29349/01A patent/AU760576C/en not_active Expired
- 2001-01-10 PT PT01942300T patent/PT1255552E/pt unknown
- 2001-01-10 AT AT01942300T patent/ATE290383T1/de active
-
2002
- 2002-06-18 IL IL150306A patent/IL150306A/en unknown
- 2002-07-08 ZA ZA200205433A patent/ZA200205433B/xx unknown
- 2002-12-13 HK HK02109079.3A patent/HK1047700B/zh not_active IP Right Cessation
-
2007
- 2007-07-18 JP JP2007186380A patent/JP2007302690A/ja active Pending
-
2014
- 2014-01-06 BE BE2014C001C patent/BE2014C001I2/fr unknown
Also Published As
Publication number | Publication date |
---|---|
ATE290383T1 (de) | 2005-03-15 |
ES2236245T3 (es) | 2005-07-16 |
HK1047700A1 (en) | 2003-03-07 |
AU760576C (en) | 2004-04-08 |
EP1255552A1 (fr) | 2002-11-13 |
EP1255552B1 (fr) | 2005-03-09 |
HK1047700B (zh) | 2005-05-27 |
IL150306A0 (en) | 2002-12-01 |
CN1394140A (zh) | 2003-01-29 |
ZA200205433B (en) | 2003-11-26 |
KR100614361B1 (ko) | 2006-08-18 |
CA2395217A1 (fr) | 2001-07-19 |
CA2395217C (fr) | 2004-10-26 |
HUP0204159A3 (en) | 2005-03-29 |
PT1255552E (pt) | 2005-06-30 |
HUP0204159A2 (hu) | 2003-04-28 |
DE60109274D1 (de) | 2005-04-14 |
IL150306A (en) | 2007-06-03 |
US6323241B1 (en) | 2001-11-27 |
DE60109274T2 (de) | 2006-02-09 |
AU760576B2 (en) | 2003-05-15 |
BR0107478A (pt) | 2002-09-03 |
AU2934901A (en) | 2001-07-24 |
KR20020073498A (ko) | 2002-09-26 |
JP2007302690A (ja) | 2007-11-22 |
MXPA02006758A (es) | 2008-09-12 |
JP2003519657A (ja) | 2003-06-24 |
TR200201769T2 (tr) | 2002-11-21 |
WO2001051053A1 (fr) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2014C001I2 (fr) | ||
IL160404A0 (en) | Prostaglandin compositions and methods of treatment for male erectile dysfunction | |
ATE273714T1 (de) | Topische zusammensetzungen zur prostaglandin e1 abgabe | |
TR200202308T2 (tr) | Prostaglandin E1 içeren tropikal bileşimler | |
NO934355L (no) | Proteinformulering omfattende veksthormon | |
ES2187820T3 (es) | Formulaciones farmaceuticas de factor de liberacion de la corticotrop ina que tiene una estabilidad en su forma liquida. | |
NO934107D0 (no) | Penetrasjonsfremmende substans | |
CA2442479A1 (fr) | Compositions topiques d'apport de prostaglandine e1 |